These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 10568851)
21. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A. Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772 [TBL] [Abstract][Full Text] [Related]
22. Functional interaction between N-methyl-D-aspartate receptor and ascorbic acid during neuropathic pain induced by chronic constriction injury of the sciatic nerve. Saffarpour S; Nasirinezhad F J Basic Clin Physiol Pharmacol; 2017 Nov; 28(6):601-608. PubMed ID: 28902622 [TBL] [Abstract][Full Text] [Related]
23. [BK(Ca) channel agonist NS1619 and Kv channel antagonist 4-AP on the facial mechanical pain threshold in a rat model of chronic constriction injury of the infraorbital nerve]. Liu CY; Li N; Zhao YF; Ma B Sheng Li Xue Bao; 2010 Oct; 62(5):441-9. PubMed ID: 20945047 [TBL] [Abstract][Full Text] [Related]
24. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Ossipov MH; Lopez Y; Nichols ML; Bian D; Porreca F Neurosci Lett; 1995 Oct; 199(2):87-90. PubMed ID: 8584250 [TBL] [Abstract][Full Text] [Related]
25. Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus. Bordi F; Quartaroli M Pain; 2000 Feb; 84(2-3):213-24. PubMed ID: 10666526 [TBL] [Abstract][Full Text] [Related]
26. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809 [TBL] [Abstract][Full Text] [Related]
27. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine. Lutfy K; Doan P; Weber E Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659 [TBL] [Abstract][Full Text] [Related]
28. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Warncke T; Stubhaug A; Jørum E Pain; 1997 Aug; 72(1-2):99-106. PubMed ID: 9272793 [TBL] [Abstract][Full Text] [Related]
29. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys. Allen RM; Dykstra LA J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554 [TBL] [Abstract][Full Text] [Related]
30. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Leung A; Wallace MS; Ridgeway B; Yaksh T Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090 [TBL] [Abstract][Full Text] [Related]
31. Effects of the combined continuous administration of morphine and the high-efficacy 5-HT1A agonist, F 13640 in a rat model of trigeminal neuropathic pain. Deseure KR; Adriaensen HF; Colpaert FC Eur J Pain; 2004 Dec; 8(6):547-54. PubMed ID: 15531223 [TBL] [Abstract][Full Text] [Related]
32. The 5-HT(1A) receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain. Deseure K; Koek W; Colpaert FC; Adriaensen H Eur J Pharmacol; 2002 Dec; 456(1-3):51-7. PubMed ID: 12450569 [TBL] [Abstract][Full Text] [Related]
33. Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-Fos expression. Honoré P; Chapman V; Buritova J; Besson JM Anesthesiology; 1996 Jul; 85(1):150-60. PubMed ID: 8694361 [TBL] [Abstract][Full Text] [Related]
34. Blockade of NMDA Receptors and Nitric Oxide Synthesis Potentiated Morphine-Induced Anti-Allodynia via Attenuating Pain-Related Amygdala pCREB/CREB Signaling Pathway. Tolou-Dabbaghian B; Delphi L; Rezayof A J Pain; 2019 Aug; 20(8):885-897. PubMed ID: 30707953 [TBL] [Abstract][Full Text] [Related]
35. The role of large-conductance, calcium-activated potassium channels in a rat model of trigeminal neuropathic pain. Liu CY; Lu ZY; Li N; Yu LH; Zhao YF; Ma B Cephalalgia; 2015 Jan; 35(1):16-35. PubMed ID: 24820887 [TBL] [Abstract][Full Text] [Related]
37. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats. Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634 [TBL] [Abstract][Full Text] [Related]
38. Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats. Makuch W; Mika J; Rojewska E; Zychowska M; Przewlocka B Neuropharmacology; 2013 Dec; 75():445-57. PubMed ID: 24035921 [TBL] [Abstract][Full Text] [Related]
39. Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat. Le Guen S; Catheline G; Besson JM Eur J Pharmacol; 1999 May; 373(1):1-11. PubMed ID: 10408246 [TBL] [Abstract][Full Text] [Related]
40. Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain. Villetti G; Bergamaschi M; Bassani F; Bolzoni PT; Maiorino M; Pietra C; Rondelli I; Chamiot-Clerc P; Simonato M; Barbieri M J Pharmacol Exp Ther; 2003 Aug; 306(2):804-14. PubMed ID: 12750440 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]